Company: INMB
Filing Date: 2025-06-16
Form Type: S-8
Source: 0001213900-25-054428
Chunk: 11

Company: Inmune Bio, Inc.
Filing Date: 2025-06-16
Form: S-8
Chunk 11
---
 which the broker solicits purchasers; |

| 4. | through                        
 options, swaps or derivatives; |

| 5. | in                                 
 transactions to cover short sales; |

| 6. | privately                   
 negotiated transactions; or |

| 7. | in                                         
 a combination of any of the above methods. |

The selling stockholders may sell their shares
of common stock directly to purchasers or may use brokers, dealers, underwriters or agents to sell their shares of common stock. Brokers
or dealers engaged by the selling stockholders may arrange for other brokers or dealers to participate. Brokers or dealers may receive
commissions, discounts or concessions from the selling stockholders, or, if any such broker-dealer acts as agent for the purchaser of
shares of common stock, from the purchaser in amounts to be negotiated immediately prior to the sale. The compensation received by brokers
or dealers may, but is not expected to, exceed that which is customary for the types of transactions involved.

Broker-dealers may agree with a selling stockholder
to sell a specified number of shares of common stock at a stipulated price per common share, and, to the extent the broker-dealer is unable
to do so acting as agent for a selling stockholder, to purchase as principal any unsold shares of common stock at the price required to
fulfill the broker-dealer commitment to the selling stockholder.

<div align='center'>5</div>

Broker-dealers who acquire shares of common stock
as principal may thereafter resell the shares of common stock from time to time in transactions, which may involve block transactions
and sales to and through other broker-dealers, including transactions of the nature described above, on the Nasdaq Capital Market or otherwise
at prices and on terms then prevailing at the time of sale, at prices then related to the then-current market price or in negotiated transactions.
In connection with resales of the shares of common stock, broker-dealers may pay to or receive from the purchasers of shares commissions
as described above.

If the selling stockholders enter into arrangements
with brokers or dealers, as described above, we are obligated to file a post-effective amendment to this registration statement disclosing
such arrangements, including the names of any broker-dealers acting as underwriters.

The selling stockholders and any broker-dealers
or agents that participate with the selling stockholders in the sale of the shares of common stock may be deemed to be “underwriters”
within the meaning of the Securities Act. In